Scholarly Index
Mark D. Pegram
Stanford University; 41,356 total citations; 345 total publications; best world rank #171
Stanford University
41,356Total citations
345Total publications
66H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 407 | US 243 | 99.25 |
| Cancer Treatment and Pharmacology | Lifetime | 276 | US 155 | 99.16 |
| HER2/EGFR in Cancer Research | Lifetime | 186 | US 90 | 99.14 |
| Peptidase Inhibition and Analysis | Lifetime | 600 | US 274 | 97.97 |
| Advanced Breast Cancer Therapies | Lifetime | 236 | US 112 | 98.05 |
| Breast Cancer Treatment Studies | Lifetime | 732 | US 328 | 97.89 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 636 | US 257 | 96.97 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 242 | US 88 | 95.69 |
| HER2/EGFR in Cancer Research | 2021-2025 | 171 | US 60 | 97.43 |
| Cancer Treatment and Pharmacology | 2021-2025 | 289 | US 101 | 94.29 |
| Brain Metastases and Treatment | 2021-2025 | 489 | US 225 | 89.12 |
| Advanced Breast Cancer Therapies | 2021-2025 | 662 | US 232 | 87.86 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 906 | US 217 | 85.92 |